Jun Fang

Idarubicin-intensified haploidentical HSCT with GvHD prophylaxis of ATG and basiliximab provides comparable results to sibling donors in high-risk acute leukemia

X. Lu, R. Zhang, W. Shi, 2017, Bone Marrow Transplantation.

Idarubicin-intensified BUCY2 regimens may lower relapse rate and improve survival in patients undergoing allo-SCT for high-risk hematological malignancies: a retrospective analysis

P. Zou, L. Xia, Z. Zhong, 2012, Bone Marrow Transplantation.